Sustainability
is deep rooted in all
our decision making
We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
LATEST
News Updates
28 MAY 2026
Pharmaniaga Berhad (“Pharmaniaga” or “the Group”) continues to strengthen its position in Malaysia’s healthcare sector with the award of a significant contract to supply human insulin to public healthcare institutions nationwide, reinforcing its standing as a key player within the country’s pharmaceutical and healthcare ecosystem.
19 MAY 2026
Pharmaniaga Berhad (Pharmaniaga or The Group) today secured shareholder approval for its proposed share consolidation exercise at the Group’s Extraordinary General Meeting (EGM), marking another important step in reinforcing the Group’s market positioning and strengthening investor confidence following its successful financial turnaround and return to a stronger footing.
18 MAY 2026
Pharmaniaga Berhad (Pharmaniaga or The Group) carried its recovery momentum firmly into financial year 2026 (FY2026), delivering a strong first quarter performance with profit after tax (PAT) of RM32.2 million for the quarter ended 31 March 2026 (Q1FY2026), reflecting the Group’s strengthening fundamentals and continued operational resilience.
16 MARCH 2026
Pharmaniaga Berhad (“Pharmaniaga” or “the Group”) today announced the successful upliftment of its Practice Note 17 (PN17) status by Bursa Malaysia Securities Berhad (“Bursa”), effective tomorrow. This marks a significant key milestone in the Group’s recovery and renewed growth trajectory.
23 FEBRUARY 2026
Pharmaniaga Berhad (Pharmaniaga or the Group) recorded a Profit After Tax (PAT) of RM8.7 million for the fourth quarter ended 31 December 2025 (Q4FY2025), marking its eight consecutive profitable quarter and strengthening the Group’s financial recovery and momentum towards exiting PN17.
INTEGRATED
REPORT
2025
_____________________